These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9124666)

  • 1. Cholinesterase. Its significance in anaesthetic practice.
    Davis L; Britten JJ; Morgan M
    Anaesthesia; 1997 Mar; 52(3):244-60. PubMed ID: 9124666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cholinesterases].
    Lejus C; Blanloeil Y; Burnat P; Souron R
    Ann Fr Anesth Reanim; 1998; 17(9):1122-35. PubMed ID: 9835982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical importance of plasma cholinesterase for the anaesthetist.
    Pedersen NA; Jensen FS
    Ann Acad Med Singap; 1994 Nov; 23(6 Suppl):120-4. PubMed ID: 7710221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the enzymic degradation of suxamethonium and mivacurium increases the onset time of submaximal neuromuscular block.
    Beaufort TM; Nigrovic V; Proost JH; Houwertjes MC; Wierda JM
    Anesthesiology; 1998 Sep; 89(3):707-14. PubMed ID: 9743409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mivacurium-induced prolonged neuromuscular block.
    Sockalingam I; Green DW
    Br J Anaesth; 1995 Feb; 74(2):234-6. PubMed ID: 7696076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma cholinesterase variants and the anaesthetist.
    Whittaker M
    Anaesthesia; 1980 Feb; 35(2):174-97. PubMed ID: 6992635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudocholinesterase-mediated hydrolysis is superior to neostigmine for reversal of mivacurium-induced paralysis in vitro.
    Yang HS; Goudsouzian N; Martyn JA
    Anesthesiology; 1996 Apr; 84(4):936-44. PubMed ID: 8638849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged neuromuscular block associated with mivacurium.
    Fox MH; Hunt PC
    Br J Anaesth; 1995 Feb; 74(2):237-8. PubMed ID: 7696077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Edrophonium requirements for reversal of deep neuromuscular block following infusion of mivacurium.
    Miller DR; Bryson G; Martineau RJ; Kitts JB; Curran M; Bragg P; Watson JB; Hull K; Lindsay P
    Can J Anaesth; 1995 Nov; 42(11):996-1002. PubMed ID: 8590511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suxamethonium and mivacurium sensitivity from pregnancy-induced plasma cholinesterase deficiency.
    Davies P; Landy M
    Anaesthesia; 1998 Nov; 53(11):1109-11. PubMed ID: 10023281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholinesterase inhibition by potato glycoalkaloids slows mivacurium metabolism.
    McGehee DS; Krasowski MD; Fung DL; Wilson B; Gronert GA; Moss J
    Anesthesiology; 2000 Aug; 93(2):510-9. PubMed ID: 10910502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mivacurium. A review of its pharmacology and therapeutic potential in general anaesthesia.
    Frampton JE; McTavish D
    Drugs; 1993 Jun; 45(6):1066-1089. PubMed ID: 7691494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Frequency distribution of dibucaine numbers in 24,830 patients].
    Pestel G; Sprenger H; Rothhammer A
    Anaesthesist; 2003 Jun; 52(6):495-9. PubMed ID: 12835869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuromuscular effects of mivacurium in 2- to 12-yr-old children with burn injury.
    Martyn JA; Goudsouzian NG; Chang Y; Szyfelbein SK; Schwartz AE; Patel SS
    Anesthesiology; 2000 Jan; 92(1):31-7. PubMed ID: 10638896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cumulative reduction in serum cholinesterase following repeated therapeutic plasma exchange.
    Collard CD; Baker BW; Johnson D; Bressler R; Harati Y
    J Clin Anesth; 1996 Feb; 8(1):44-8. PubMed ID: 8695079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mivacurium sensitivity in a patient heterozygous for the atypical and silent genes for plasma cholinesterase.
    Robertson WS; Shaikh J; Purdie DW
    Ann Clin Biochem; 1995 Jul; 32 ( Pt 4)():431-3. PubMed ID: 7486808
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of plasma cholinesterase in anesthesiology.
    FOLDES FF; RHODES DH
    Curr Res Anesth Analg; 1953; 32(5):305-18. PubMed ID: 13094948
    [No Abstract]   [Full Text] [Related]  

  • 18. Reversal of intense mivacurium block with human plasma cholinesterase in patients with atypical plasma cholinesterase.
    Ostergaard D; Jensen FS; Viby-Mogensen J
    Anesthesiology; 1995 May; 82(5):1295-8. PubMed ID: 7741307
    [No Abstract]   [Full Text] [Related]  

  • 19. Prolonged neuromuscular block due to cholinesterase depletion by plasmapheresis.
    Naik B; Hirshhorn S; Dharnidharka VR
    J Clin Anesth; 2002 Aug; 14(5):381-4. PubMed ID: 12208445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and pharmacodynamics of mivacurium in patients phenotypically homozygous for the atypical plasma cholinesterase variant: effect of injection of human cholinesterase.
    Østergaard D; Viby-Mogensen J; Rasmussen SN; Gätke MR; Varin F
    Anesthesiology; 2005 Jun; 102(6):1124-32. PubMed ID: 15915024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.